GLP-1 Diabetes Medications Associated with Lower Risk of Addiction and Substance-Related Mortality
Glucagon-like peptide-1 (GLP-1) receptor agonists, primarily developed as therapeutic agents for type 2 diabetes mellitus and obesity, are emerging as ...
